文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

位置扫描确定了弗林蛋白酶和PACE4的高亲和力多亮氨酸抑制剂的分子决定因素。

Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.

作者信息

Małuch Izabela, Levesque Christine, Kwiatkowska Anna, Couture Frédéric, Ly Kévin, Desjardins Roxane, Neugebauer Witold A, Prahl Adam, Day Robert

机构信息

Department of Organic Chemistry, Faculty of Chemistry, University of Gdańsk , 80-308 Gdańsk, Poland.

Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke , 3001 12e Avenue Nord, Sherbrooke J1H 5N4, Canada.

出版信息

J Med Chem. 2017 Apr 13;60(7):2732-2744. doi: 10.1021/acs.jmedchem.6b01499. Epub 2017 Mar 24.


DOI:10.1021/acs.jmedchem.6b01499
PMID:28287731
Abstract

The proprotein convertase family of enzymes includes seven endoproteases with significant redundancy in their cleavage activity. We previously described the peptide Ac-LLLLRVK-Amba that displays potent inhibitory effects on both PACE4 and prostate cancer cell lines proliferation. Herein, the molecular determinants for PACE4 and furin inhibition were investigated by positional scanning using peptide libraries that substituted its leucine core with each natural amino acid. We determined that the incorporation of basic amino acids led to analogues with improved inhibitory potency toward both enzymes, whereas negatively charged residues significantly reduced it. All the remaining amino acids were in general well tolerated, with the exemption of the P6 position. However, not all of the potent PACE4 inhibitors displayed antiproliferative activity. The best analogues were obtained by the incorporation of the Ile residue at the P5 and P6 positions. These substitutions led to inhibitors with increased PACE4 selectivity and potent antiproliferative effects.

摘要

前体蛋白转化酶家族的酶包括七种内切蛋白酶,它们的切割活性具有显著的冗余性。我们之前描述了肽Ac-LLLLRVK-Amba,它对PACE4和前列腺癌细胞系的增殖均显示出强效抑制作用。在此,通过使用用每种天然氨基酸取代其亮氨酸核心的肽库进行位置扫描,研究了PACE4和弗林蛋白酶抑制的分子决定因素。我们确定,碱性氨基酸的掺入导致对这两种酶具有更高抑制效力的类似物,而带负电荷的残基则显著降低了抑制效力。除P6位置外,所有其余氨基酸一般都具有良好的耐受性。然而,并非所有强效的PACE4抑制剂都具有抗增殖活性。通过在P5和P6位置掺入异亮氨酸残基获得了最佳类似物。这些取代导致了具有更高PACE4选择性和强效抗增殖作用的抑制剂。

相似文献

[1]
Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.

J Med Chem. 2017-4-13

[2]
Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.

Eur J Cell Biol. 2017-8

[3]
Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.

J Med Chem. 2018-12-13

[4]
Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors.

ChemMedChem. 2016-2-4

[5]
Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.

J Med Chem. 2018-9-17

[6]
Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.

Int J Biol Sci. 2010-2-3

[7]
The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells.

J Med Chem. 2012-11-14

[8]
PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.

Neoplasia. 2014-8

[9]
Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.

Gut. 2008-11

[10]
Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor.

J Med Chem. 2013-12-18

引用本文的文献

[1]
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding.

J Allergy Clin Immunol. 2025-4-29

[2]
Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin.

ACS Med Chem Lett. 2021-2-5

[3]
Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.

Sci Rep. 2019-2-14

[4]
Current Challenges and Opportunities in Treating Glioblastoma.

Pharmacol Rev. 2018-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索